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Abstract
Cancer is causing a lot of  suffering and death in Africa but  is 
not considered a major health problem in Africa. This needs 
to change. Cancer should be given equal emphasis to HIV/
AIDS, tuberculosis (TB) and Malaria. 
A national cancer policy is required in Malawi to develop 
and improve evidence-based cancer prevention, early 
diagnosis, curative and palliative therapy. A national cancer 
policy is crucial to ensure a priotised, clear, coordinated  and 
sustained fight against cancer. When no policy exists, events 
are likely to be random, stakeholders and practitioners in 
the fight against cancer may not agree on how to proceed, 
may duplicate efforts or may neglect areas that would have 
greater nationwide impact resulting in poor quality activities 
and haphazard development. 
Introduction
In Africa, cancer is not considered an essential health issue 
1  and is not recognized as a major cause of  death2.  Cancer 
is not mentioned in the Millennium Development Goals 
(MDGs) 3; and Malawi’s Essential Health Package (EHP) – 
which includes “health services addressing the major causes 
of  death and disease in Malawi” does not include cancer 4. 
Official documentation explicitly and implicitly states that 
EHP only includes funds for priority areas in the health 
sector in Malawi 4.  In May 2002, the direct annual cost of  the 
EHP components was estimated at nearly US$83,000,000. 
This covered:- vaccine preventable diseases; acute respiratory 
infections in under 5s; malaria; adverse maternal and 
neonatal outcomes; tuberculosis; acute diarrhoeal diseases; 
STIs including HIV/AIDS; schistosomiasis; nutritional 
deficiencies; eye, ear and skin conditions; and common 
injuries 4. Cancer was not included as a specific component.
In reality, cancer is a major cause of  mortality and morbidity 
in developing countries. Lack of  accurate population based 
data and the weakness of  health information systems mean 
that there is scarce information on the burden and pattern 
of  cancer in Africa. However, statistical analyses allow us to 
derive estimates based on few available local data and local 
studies. The local data itself, even if  it were accurate, is likely 
to grossly under-represent cancer diagnoses owing to lack of  
capacity to confirm diagnoses. In spite of  this, the available 
estimates should not be ignored. Globocan, a worldwide 
database deriving estimates from available cancer registries 
(Malawi National Cancer Registry included), recorded 
582,000 cases of  cancer in Africa in 2002 and this figure is 
expected to double in the next two decades if  interventions 
are not intensified 5. In the same year of  2002, more people 
died of  cancer worldwide (7.6 million) than died of  HIV/
AIDS, TB and malaria combined (5.6 million) worldwide6. 
Although this is a global figure, we can speculate that a 
measure of  success in tackling HIV/AIDS, TB and malaria in 
the developing world has reduced death rates to levels which 
are comparable with cancer deaths on account of  high case 
fatality rate for cancers in the developing world. The World 
Health Organisation (WHO) has estimated that the global 
cancer  burden will increase to 16 million new cases per 
year by 2020 with 70% of  these occurring in the developing 
world;  Africa will account for more than 1 million of  these 
cases 7.  In Africa in general, the most common cancers in 
women are cervical cancer and breast carcinoma; and in men 
are prostate and liver cancer 8,9. Liver cancer is responsible 
for the most cancer deaths in men in Africa as a whole9.
The available data in Malawi suggests that cancer incidence 
is increasing in the country. In the pre-HIV era, cancer of  
the oesophagus (12.8%) was reported as the most common 
cancer in males followed by bladder cancer (7.4%), Non 
Hodgkin’s Lymphoma (NHL) (7.1%) and Kaposi’s sarcoma 
(KS) - 6.6%; whereas in females the most common cancer was 
cervical cancer (36.6%) followed by bladder cancer (6.8%) 
and breast cancer (6.7%) 10. The AIDS epidemic has meant 
that Kaposi’s sarcoma is now the most common cancer in 
Malawi similarly in Uganda, Swaziland, and Zimbabwe 7. 
Blantyre is the only district covered by population based 
cancer registration in Malawi 11. In this district, the five most 
common cancers in order of  frequency between 1994 and 
1998 in males were KS, cancer of  the oesophagus, prostate 
cancer, liver cancer and bladder cancer/NHL. In females 
the most common cancers were cervical cancer, KS, cancer 
of  the oesophagus, breast cancer and NHL. In children 
the most common cancer were lymphoma, retinoblastoma, 
Burkitt’s lymphoma, Wilm’s tumour/KS, and connective 
tissue cancers 11.  In 2002, the three most common cancers 
in Malawi in order of  frequency were:- KS, cervical cancer, 
and oesophageal cancer 5.  Of  note is the fact that Malawi 
is one of  the few countries in Africa where the incidence of  
oesophageal cancer appears unusually high 12 .   
Cancer patients in Africa face a poor outcome13. There is a 
general lack of  understanding about the nature of  cancer 
disease. People think it is witchcraft and others do not 
recognise their tumours or wasting as a serious disease. 
Society may shun cancer patients resulting in them being too 
ashamed to seek help. Most patients with cancer present to 
hospital late 14.
These cancer trends suggest that unless urgent action is taken 
to try to control the rising incidence of  cancer throughout 
Africa, thousands of  lives will be lost to the disease. The 
May 2007 London Declaration on Cancer calls on research 
institutions, international organisations, the pharmaceutical 
industry, national governments, and civil society in developed 
and developing countries “to unite and work together to bring 
comprehensive cancer care to Africa” 15. Communicable diseases 
should not be neglected,  but rather cancer should be given 
equal priority to diseases such as HIV/AIDS, TB and Malaria 
– there is no “either or”. The two main areas to address in 
the fight against cancer in Malawi are: (1) reduction of  the 
incidence and mortality of  cancer and (2) improvement of  
the quality of  life of  cancer patients.
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Reducing the incidence of cancer in Malawi
In order to effect appropriate measures to reduce cancer 
incidence, an accurate assessment of  the incidence and 
outcome of  cancer is required in Malawi by way of  a 
nationwide population based cancer registration such as 
the Malawi National Cancer Registry (MNCR). MNCR is 
based in Blantyre and is the only histopathology service 
in Malawi, therefore samples from all over the country are 
sent to Blantyre for data capture. The registry is also able 
at intervals to make visits to all parts of  Malawi to collect 
cancer data. Population-based cancer data for Blantyre allows 
for extrapolation of  cancer figures for the whole of  Malawi. 
The reliability of  MNCR data is questionable owing to (1) 
histopathology samples from distant places like Chitipa, for 
example, are not sent to Blantyre with the same frequency as 
samples from districts surrounding Blantyre; (2) practitioners 
do not send samples to Blantyre owing to delays and in some 
cases non-availability of  results when samples are sent and; 
(3) relatively few cancer patients have tissue samples taken 
owing to shortage of  surgery and invasive procedures in the 
country. Geographic variation in cancer risk factors within 
Malawi could be identified by having a reliable nationwide 
population-based cancer registration. Cancer registries need 
infrastructure, appropriate software and hardware, human 
resources and training, and incentives for sustainability. 
MNCR is currently about two years behind in its cancer 
registration activities owing to funding limitations.
Not all risk factors for cancer in Africa such as increasing 
life expectancy 16, are not preventable. However, one-third 
of  cancers are preventable. There is relative prominence of  
preventable infections as risk factors in Africa 17-19.  Five out 
of  six women with cancer of  the cervix live in developing 
countries 6. Human papillomavirus (HPV) types 16 and 18 
cause 70% of  cervical cancer cases and two vaccines that 
guard against these HPV types have been developed by the 
pharmaceutical industry.  The availability of  these vaccines 
–  still poses many unanswered questions – has immense 
potential for control of   cervical cancer 20.  However, the use 
of  the vaccines in Malawi is hampered by lack of  information 
pertaining to the types of  HPV common in Malawi. This 
needs to be studied.  
Antiretroviral therapy (ART) commenced in 2004 in Malawi 
with a nationwide roll out. ART reduces the acquisition of  
KS.  Up to date data is needed to assess the potential change 
in the spectrum of  cancer disease in the post-ART era in the 
country.
Hepatitis B (HBV) is endemic on the continent and present in 
8–16% of  the general population 21. Its effect is compounded 
by widespread exposure to aflatoxin which contaminates 
staple diets across Africa. Effective strategies are available to 
reduce the effect of  these factors on liver cancer.  It is also 
suspected that the contamination of  maize with aflatoxin 
may contribute to oesophageal cancer 22. 
Tobacco use, which might be small but increasing, is also 
another preventable factor contributing to cancers in Africa 
23.  Tobacco exports contribute the most foreign exchange 
for Malawi’s economy. Research is needed to determine the 
contribution of  tobacco to cancer in Malawi before any action 
can be taken that may needlessly jeopardise the economy. The 
decreasing number of  markets for the tobacco industry in 
the developed world has two implications for Malawi (1) the 
tobacco industry may seek to develop new markets in Africa 
which will lead to increased tobacco use (2) the strength of  
the Malawi economy may weaken thereby necessitating a shift 
away from tobacco. Strategies to control tobacco use have 
included educating civil society (with emphasis on young 
people, health-care practitioners and policy makers) about 
the dangers of  tobacco use and the benefits of  quitting; 
increasing the tax and price of  tobacco; placing of  effective 
warning labels on tobacco products; banning advertising and 
promotion of  tobacco use; prohibiting smoking in public 
places; banning sales of  single cigarettes and prohibiting the 
sales of  tobacco to the youth. 
Reducing the mortality of Cancer in Malawi
Even if  all preventive measures were fully implemented today 
they would have little effect on cancer mortality in the next 
10–15 years 23. Where prevention has failed, early diagnosis 
may allow cure of  cancer with minimal intervention. A third 
of  cancers are treatable if  detected early 24. Screening and 
cancer awareness campaigns at the primary health care level 
can facilitate early diagnosis and improve response to therapy 
25-26. 
Africa has many logistical and economical limitations. 
Malawi’s economy is very small in size and its gross national 
income per capita in 2007 was among the lowest ten in the 
world 27-28. Thus there are those who argue that for poor 
countries, emphasis should be on prevention and early 
diagnosis rather than on therapy. This presents a problem, 
without offering treatment for cancer, it is difficult for society 
to adopt prevention and early diagnostic strategies. A more 
pragmatic approach would be to address prevention, early 
diagnosis and treatment together.
International league tables have reported in the past, that the 
UK was ranked lowly in cancer survival tables, had significantly 
longer treatment waiting times, and fewer cancer specialists 
and treatment facilities than its European neighbours 1. This 
led to the creation of  a funded National Cancer Plan. A 
valuable  indicator to assess cancer expenditure in Malawi, 
is measuring cancer expenditure as a percentage of  national 
income compared with wealthy nations and neighbouring 
countries.
Basic treatments could achieve cure rates of  up to 80% 
within a few years.  In aggressive non-Hodgkin’s lymphoma 
CHOP (cyclophosphamide, doxorubicin, vincristine and 
prednisolone) can provide a cure 29. A 75 kg patient with 
a height of  163 cm would require 1,380 mg of  intravenous 
(IV) cyclophosphamide, 92 mg of  IV doxorubicin, 2 mg of  
IV vincristine and 375 mg of  oral prednisolone. At K300 
per 500mg of  cyclophosphamide IV, K5,500 per 50 mg 
IV doxorubicin, K250 per 1 mg IV vincristine and K4 per 
tablet of  prednisolone,  the patient in question would require 
CHOP costing K12,700 every 21 days; which is about K605 
per day. Where COP (cyclophosphamide, vincristine and 
prednisolone) is used for lymphoma 30, the cost is reduced 
even further. Cost-effective curative and palliative protocol-
based therapies have been shown to be successful in Africa 
31,32. 
Treating cancer requires more than just chemotherapy. 
Ideally, countries should have at least one national cancer 
centre providing surgery, radiation therapy and chemotherapy. 
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Radiation programmes can developed from models provided 
by the International Atomic Energy Agency (IAEA), and 
their Programme for Action on Cancer Treatment 33. The 
IAEA is already part of  ongoing efforts to establish a cancer 
treatment facility in Malawi34. A number of  issues need to be 
considered about this undertaking this includes radiotherapy 
equipment, radiologists, oncologists, engineers, technicians 
and nurses among other personnel. Two doctors from 
Malawi are receiving radiotherapy and oncology training in 
South Africa,  which is commendable. 
Most cancers require multimodality therapy, including 
combinations of  surgery, chemotherapy and radiotherapy. 
This means that comprehensive cancer care needs surgical 
input (surgical oncologists) and chemotherapy input 
(medical oncologists/ haemato-oncologists) in addition 
to radiotherapy.  Cancer care is best provided by a 
multidisciplinary team. In essence a cancer center must be 
able to provide all the three main modalities of  management. 
It must also be able to provide adequate diagnostic and staging 
services. Surgical oncology is greatly enhanced where there 
is availability of  pathological intraoperative consultation to 
provide services such as frozen section procedures, which 
are currently unavailable in Malawi. For these reasons, 
it has been suggested that it is better to integrate cancer 
services into an existing hospital which can provide a 
multidisciplinary platform for cancer care than establish a 
stand alone cancer centre.  Integration of  cancer services 
into existing hospital services is a realistic approach. Access 
is also an important consideration. The best diagnostic and 
staging services in Malawi are concentrated in Blantyre in 
terms of  histopathology and imaging services. This poses 
several problems for patients in distant districts like Chitipa 
and Karonga.
Improving the quality of life of cancer patients 
in Malawi
Palliative care must be a priority component of  affordable 
and effective cancer care. It provides pain and symptom 
control, terminal care and bereavement support. It has 
been suggested that because of  limited resources, Africa 
should concentrate on palliative care alone and forget about 
chemotherapy and radiotherapy 35-36. The problem with this 
line of  thought is that it violates health care principles like 
patient autonomy, prevention of  complications of  disease, 
access and equity in provision of  care. 
Traditional medicine may have a big role to play in palliative 
care in Malawi, in terms of  psychosocial support and should 
be considered for integration into a national cancer policy. 
The nature of  traditional healer’s work enables them to 
welcome patients that are being shunned by the community 
37. Traditional medical practice encourages openness 
and patients talk freely.  This forum can provide a better 
understanding of  affected person’s spiritual, psychological 
and social needs.
A national cancer policy for Malawi
In order to effect the measures that would reduce the 
incidence and mortality of  cancer; and improve the quality 
of  life of  cancer patients, Malawi needs a national cancer 
control programme. Governments  in Africa must recognise 
the growing cancer problem and develop cancer control 
programmes as a matter of  urgency.  Only two countries 
in Africa (Cameroon and South Africa) are said to have 
comprehensive national cancer control policies35. There 
have been two attempts (in 2000 and 2003) to develop a 
national cancer control policy for Malawi without success. 
Without a policy, random events, locally available resources, 
and pressure from special interest groups determine what 
actions are taken; this can result in poor-quality services and 
haphazard development. 
A national cancer control programme must be developed 
through a planned process. After considering the problem, 
the Ministry of  Health should issue general directives on 
planning programmes for cancer control. A national cancer 
policy would be the basis for planning.
National policy on cancer control was defined by the World 
Health Organisation (WHO) in 1993 as “an explicit statement 
of  intent by government which defines the objectives of  cancer control and 
the relative priority of  each objective; indicates the measures required to 
attain the objectives; and provides a basis for planning” 38.
A national cancer policy should be formulated by a national 
advisory body set up by the Ministry of  Health and then 
approved by an executive authority at the highest level. The 
membership of  the advisory group must include relevant 
stakeholders. The policy must be based on up-to-date, 
scientifically sound evidence.
The national cancer policy should contain statements on the 
objectives of  the cancer control programme, a time scale, 
provision for the facilities needed, the necessary personnel, 
resources, and funding.  Developing a policy is a dynamic 
process; requiring regular revision based on changes in 
current knowledge and technology.
The policy should enable integration of  priority health 
areas in Malawi. The EHP and the Sector Wide Approach 
(SWAp) helps donors assess Malawi’s health priority areas. 
Adding cancer to the EHP would expand competition for 
limited donor support. On the other hand, cancer could be 
integrated into existing programmes on HIV/AIDS, TB and 
Malaria.
Finally, training, education and partnership programmes 
are of  primary importance for both civil society and health 
practitioners if  a cancer care plan is to be successful and 
sustainable. Priorities include: (1) raising cancer awareness; 
(2) improving knowledge and capacity through effective 
partnerships such that expectations are understood and met 
and that the national policy is sustainable for the future; 
(3) priority-driven and resource-appropriate research and 
integration with other programmes; (4) ensuring that 
education and training programmes cover specialist and 
generic requirements, from specialist clinical disciplines to 
research training to healthcare management and operational/
logistical healthcare disciplines, as well as initial and continuing 
needs.
Recommendation
In conclusion, Malawi needs a national cancer policy to guide 
and unify various stakeholder efforts in the fight against an 
increasing cancer problem. Progressive improvements can 
be made in cancer control and management by improving 
areas such as  cancer registration, epidemiology, palliative 
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care, infra-structure, equipment, personnel and cancer 
management associated services such as pathology and 
diagnostic radiology. Instruments such as the EHP and 
MDGs should be revised to incorporate cancer control5.
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